Trials / Completed
CompletedNCT03558477
PK/PD Clinical Trial of YYD601 in Healthy Adult Male
A Dose Blocked-randomized, Open-label, Parallel Design Clinical Trial to Assess the Pharmacokinetic/Pharmacodynamic Properties and Safety of YYD601 After Oral Administration in Healthy Adult Male Volunteers(Phase 1)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Yooyoung Pharmaceutical Co., Ltd. · Industry
- Sex
- Male
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
A dose block-randomized, open-label, parallel clinical trial
Detailed description
This study to evaluate comparatively a characteristics and safety of the PK/PD of single/repeated oral administration YYD601 and Nexium tab and the effects of food influence the PK/PD of YYD601 in healthy adult male.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | YYD601 1 | YYD601 1 |
| DRUG | YYD601 2 | YYD601 2 |
| DRUG | YYD601 3 | YYD601 3 |
| DRUG | Nexium | Nexium |
Timeline
- Start date
- 2017-09-19
- Primary completion
- 2018-02-07
- Completion
- 2018-02-07
- First posted
- 2018-06-15
- Last updated
- 2018-06-15
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03558477. Inclusion in this directory is not an endorsement.